Detalhe da pesquisa
1.
Conformational control of Cas9 by CRISPR hybrid RNA-DNA guides mitigates off-target activity in T cells.
Mol Cell
; 81(17): 3637-3649.e5, 2021 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34478654
2.
Allogeneic chimeric antigen receptor-T cells with CRISPR-disrupted programmed death-1 checkpoint exhibit enhanced functional fitness.
Cytotherapy
; 25(7): 750-762, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086241
3.
High-Specificity CRISPR-Mediated Genome Engineering in Anti-BCMA Allogeneic CAR T Cells Suppresses Allograft Rejection in Preclinical Models.
Cancer Immunol Res
; 12(4): 462-477, 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38345397
4.
Harnessing type I CRISPR-Cas systems for genome engineering in human cells.
Nat Biotechnol
; 37(12): 1471-1477, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31740839
5.
Unconventional Coupling between Ligand Recognition and Allosteric Control in the Multidrug Resistance Gene Regulator, BmrR.
ChemMedChem
; 12(6): 426-430, 2017 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28090749
6.
Charge is Major Determinant of Activation of the Ligand-Responsive Multidrug Resistance Gene Regulator, BmrR.
ChemMedChem
; 11(10): 1038-41, 2016 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27010425